GSTM1 and anemia (phenotype): In early posttransplant anemia, the first RCT enrolled patients with Hb concentration of <12 g/dL in the immediate posttransplant period who were randomized to subcutaneous epoetin beta thrice weekly to target Hb concentration of >12.5 g/dL, or else to placebo.